Romidepsin Enhances the Killing Ability of NKG2D-CAR-T Cells through Enhanced Expression of NKG2DL against Ovarian Cancer Cells
Background: Upregulating tumor cell targeting antigens and improving the cytotoxicity of chimeric antigen receptor T cell (CAR-T) are expected to facilitate better treatment efficacy for solid cancers represented by ovarian cancer. Methods: Killer cell lectin-like receptor subfamily K member 1 ligan...
Saved in:
| Main Authors: | Liang Wang, Xite Lin, Lirui Yu, Pengming Sun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2022-09-01
|
| Series: | Clinical and Experimental Obstetrics & Gynecology |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/CEOG/49/10/10.31083/j.ceog4910227 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CAR-T cells dual-target CD123 and NKG2DLs to eradicate AML cells and selectively target immunosuppressive cells
by: Xin Jin, et al.
Published: (2023-12-01) -
Sodium valproate enhances efficacy of NKG2D CAR-T cells against glioblastoma
by: Junchen Liu, et al.
Published: (2025-01-01) -
Harnessing NKG2D CAR-T cells with radiotherapy: a novel approach for esophageal squamous cell carcinoma treatment
by: Tianyu Liu, et al.
Published: (2025-05-01) -
Diethyldithiocarbamate-copper complex ignites the tumor microenvironment through NKG2D-NKG2DL axis
by: Daciana C. Dumut, et al.
Published: (2025-02-01) -
Designs of NKG2D-based immunotherapeutics for cancer
by: Jianfeng Han, et al.
Published: (2025-06-01)